GSK plc DRC (GSK)

10,647.50 +210.50 (+2.02%)
Close ARS Disclaimer

GSK Financial Summary

GSK plc reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was GBP 8,147 million compared to GBP 7,829 million a year ago. Net income was GBP 1,464 million compared to GBP 10,821 million a year ago. Basic earnings per share from continuing operations was GBP 0.361 compared to GBP 0.188 a year ago. Diluted earnings per share from continuing operations was GBP 0.356 compared to GBP 0.186 a year ago. Basic earnings per share was GBP 0.361 compared to GBP 2.685 a year ago. Diluted earnings per share was GBP 0.356 compared to GBP 2.647 a year ago.For the nine months, sales was GBP 22,276 million compared to GBP 21,948 million a year ago. Net income was GBP 4,578 million compared to GBP 13,461 million a year ago. Basic earnings per share from continuing operations was GBP 1.13 compared to GBP 0.736 a year ago. Diluted earnings per share from continuing operations was GBP 1.114 compared to GBP 0.725 a year ago. Basic earnings per share was GBP 1.13 compared to GBP 3.345 a year ago. Diluted earnings per share was GBP 1.114 compared to GBP 3.297 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
GSK
Gross margin TTM 72.34%
Operating margin TTM 27.71%
Net Profit margin TTM 16.25%
Return on Investment TTM 24.71%
Total Revenue
Net Income
Title
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Total Revenue 8,052 8,147 7,178 6,951
Gross Profit 5,237 5,904 5,279 5,043
Operating Income 1,639 2,556 2,051 1,769
Net Income 350 1,464 1,624 1,490
Clear All
0Selected
Please try another search
GSK
Quick Ratio MRQ 0.55
Current Ratio MRQ 0.88
LT Debt to Equity MRQ 106.05%
Total Debt to Equity MRQ 135%
Total Assets
Total Liabilities
Title
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Total Assets 59,005 60,862 59,461 58,596
Total Liabilities 46,210 48,243 47,302 47,284
Total Equity 12,795 12,619 12,159 11,312
Clear All
0Selected
Please try another search
GSK
Cash Flow/Share TTM 1.66
Revenue/Share TTM 7.44
Operating Cash Flow 15.17%
Cash
Net Change in Cash
Title
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Cash From Operating Activities 3,196 2,212 1,307 53
Cash From Investing Activities 268 -491 -964 -408
Cash From Financing Activities -3,592 -1,762 31 -318
Net Change in Cash -162 -18 317 -704
Clear All
0Selected
Please try another search

* In Millions of GBP (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles